.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Deloitte
McKinsey
Argus Health
Cantor Fitzgerald
Healthtrust
Harvard Business School
Colorcon
Federal Trade Commission
Mallinckrodt

Generated: September 23, 2017

DrugPatentWatch Database Preview

COMPAZINE Drug Profile

« Back to Dashboard

What is the patent landscape for Compazine, and when can generic versions of Compazine launch?

Compazine is a drug marketed by Glaxosmithkline and is included in seven NDAs.

The generic ingredient in COMPAZINE is prochlorperazine edisylate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.

Summary for Tradename: COMPAZINE

Patents:0
Applicants:1
NDAs:7
Bulk Api Vendors: see list12
Clinical Trials: see list12
Patent Applications: see list272
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COMPAZINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL011000-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine
SUPPOSITORY;RECTAL011127-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL011000-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
TABLET;ORAL010571-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine
SUPPOSITORY;RECTAL011127-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine edisylate
CONCENTRATE;ORAL011276-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL011000-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL011000-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL021019-002Oct 6, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL021019-001Oct 6, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Cantor Fitzgerald
Fuji
Chubb
US Army
Johnson and Johnson
Federal Trade Commission
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot